Table II.

Clinical laboratory findings of ischemic stroke patients and controls

Variables	Controls (n = 74)	Ischemic stroke
		LAA (n = 86)	SAO (n = 67)
CXCL16 [ng/ml]	2.04 (1.80, 2.26)	2.36 (2.03, 2.68)*,#	2.13 (1.92, 2.50)Δ
hs-CRP [mmol/l]	1.13 (0.65, 1.69)	3.43 (1.55, 10.47)*,†	1.41 (0.93, 3.85)*
Fg [g/l]	2.40 (1.80, 2.26)	3.14 (2.51, 3.70)*	2.74 (2.56, 3.40)*
TC [mmol/l]	4.51 ±1.00	4.89 ±1.19	4.80 ±1.13
TG [mmol/l]	1.42 ±0.37	1.78 ±0.59*	1.63 ±0.49D
LDL [mmol/l]	2.49 ±0.70	2.85 ±0.92*	2.85 ±0.83*
HDL [mmol/l]	1.31 ±0.31	1.24 ±0.24	1.27 ±0.28

Data presented as mean ± SD or median (interquartile range) for variables; ischemic stroke vs. controls:

^*p < 0.01

^Δp < 0.05

LAA vs. SAO

^†p < 0.01

^#p < 0.05

TC – total cholesterol, TG – triglycerides, LDL – low-density lipoprotein, HDL – high-density lipoprotein, hs-CRP – high sensitivity C-reactive protein, Fg – fibrinogen